| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
|---|
| 12/08/2009 | CA2375986C Substituted pyrazole compounds |
| 12/02/2009 | EP1583742B1 Cb 1 receptour inverse agonists |
| 12/01/2009 | US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 12/01/2009 | CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 11/26/2009 | US20090291963 Substituted indoles |
| 11/25/2009 | EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme |
| 11/25/2009 | EP1242385B1 Cytokine, especially tnf-alpha, inhibitors |
| 11/25/2009 | EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides |
| 11/24/2009 | US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis |
| 11/24/2009 | CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 11/24/2009 | CA2433197C Gyrase inhibitors and uses thereof |
| 11/24/2009 | CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/18/2009 | EP0892789B2 Irreversible inhibitors of tyrosine kinases |
| 11/17/2009 | US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 11/17/2009 | CA2372691C Antifungal ethers |
| 11/11/2009 | CN100558697C Cycloalkyl inhibitors of potassium channel function |
| 11/10/2009 | CA2315262C Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 11/03/2009 | CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation |
| 11/03/2009 | CA2410037C 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 10/29/2009 | US20090269673 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups |
| 10/28/2009 | EP2112228A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent |
| 10/27/2009 | US7608633 1-(4-Octylphenoxy)-3-(pyrrol-1-yl)propan-2-one, for example; for preventing and treating diseases caused by an increased activity of this enzyme, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxic shock |
| 10/27/2009 | US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage |
| 10/27/2009 | CA2376355C N-heterocyclic derivatives as nos inhibitors |
| 10/20/2009 | CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection |
| 10/20/2009 | CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 10/20/2009 | CA2407371C Quinazoline derivatives for the treatment of tumours |
| 10/15/2009 | US20090258884 Substituted amides |
| 10/14/2009 | EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 10/13/2009 | CA2521846C Reverse-turn mimetics and method relating thereto |
| 10/06/2009 | US7598386 Sulphones which modulate the action of gamma-secretase |
| 10/06/2009 | US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
| 09/30/2009 | CN100545133C Use of composition of ionic nature as substitute reagent, composition constituting fluorination reagent and using method thereof |
| 09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 09/29/2009 | CA2449800C Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives |
| 09/29/2009 | CA2371853C Heterocyclic benzenesulphonamide compounds as bradykinin antagonists |
| 09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/22/2009 | CA2474627C R-(-)-1-[2-(7-chlorobenzo[b]thiophen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1h-imidazole |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |
| 09/22/2009 | CA2396720C Thiazolyl amide derivatives |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/09/2009 | EP1532109B1 Pyrrolidine derivatives as oxytocin antagonists |
| 09/09/2009 | EP0999835B1 Imidazole derivatives as mdr modulators |
| 09/09/2009 | CN100537542C Farnesyl protein transferase inhibitors as antitumor agents |
| 09/08/2009 | US7585994 used in electrolytes, batteries, capacitors, supercapacitors, and galvanic cells; N,N-dimethylpyrrolidinium trifluoromethanesulfonate; methyl(triethyl)phosphonium trifluoromethanesulfonate |
| 09/08/2009 | CA2295090C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 09/08/2009 | CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates |
| 09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215712 Pyrazole derivatives |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/25/2009 | US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia |
| 08/25/2009 | US7579379 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 08/25/2009 | US7579369 CB 1 receptor inverse agonists |
| 08/25/2009 | US7579352 Retinoic acid mimetic anilides |
| 08/20/2009 | US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP1495036B1 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates |
| 08/12/2009 | EP1399417B1 Method for producing perfluoroalkanesulfonic acid esters |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/05/2009 | EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade |
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP2085378A1 Perfluor alkane sulphonic acid salts |
| 08/05/2009 | EP1475370B1 Optically active azole derivative and process for producing the same |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN100522976C Novel azacyclic ethynyl derivatives |
| 08/05/2009 | CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 07/29/2009 | EP2082740A2 Use of imidazole derivatives as MDR modulators |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/16/2009 | WO2009089482A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
| 07/16/2009 | CA2727055A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
| 07/15/2009 | CN100513392C Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509804C N-substituted piperidine derivatives as serotonin receptor agents |
| 07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |
| 07/08/2009 | CN100509779C Dithiocarbamate |
| 07/02/2009 | US20090170922 Benzimidazole derivatives and their use as a medicament |
| 06/24/2009 | EP1205559B1 Method for detecting pathogenic microorganisms and antimicrobial agents, method for evaluating the drug effect of antimicrobial agents, and antimicrobial agents |
| 06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/23/2009 | US7550491 Ionic liquids having [N(CF3)2]− anions |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | CA2362728C Improved aqueous solubility pharmaceutical formulations |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP1485381B1 Azolylaminoazine as inhibitors of protein kinases |
| 06/11/2009 | US20090149444 Benzylamine analogues |
| 06/11/2009 | US20090148531 Rate-controlled particles |